Morgan Wolfe, 40, from Aurora, Colorado, received the Johnson & Johnson vaccine on April 1
One week later, she began experiencing a headache, dizziness, fatigue, chills and changes to her vision
Wolfe went to the ER 12 days later, where CT scans show blood clots in her brain and her lungs
On the same day, the CDC and FDA recommended a pause of the J&J vaccine following blood clot concerns
After the CDC warned that the blood clotting medication heparin could make the condition worse, doctors tried an alternative called bivalirudin
The medication worked and Wolfe was discharged from the hospital six days later